Peter J. Fromen
Chief Executive Officer chez Biomodal Ltd.
Postes actifs de Peter J. Fromen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biomodal Ltd.
 Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 18/07/2022 | - |
| Chief Executive Officer | 18/07/2022 | - |
Historique de carrière de Peter J. Fromen
Anciens postes connus de Peter J. Fromen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Corporate Officer/Principal | 08/01/2021 | 20/05/2022 |
| ILLUMINA, INC. | Investor Relations Contact | 03/06/2011 | - |
| Public Communications Contact | 01/01/2007 | 24/05/2011 | |
| Corporate Officer/Principal | - | - | |
| Sales & Marketing | 24/05/2011 | 03/06/2011 |
Formation de Peter J. Fromen
| Kenyon College | Undergraduate Degree |
| W.P. Carey School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Bourse
- Insiders
- Peter J. Fromen
- Expérience
